Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as C-Met inhibitors

Details for Australian Patent Application No. 2006296468 (hide)

Owner Aventis Pharma S.A.

Inventors Nemecek, Conception; Clerc, Francois

Agent A J Park

Pub. Number AU-B-2006296468

PCT Pub. Number WO2007/036630

Priority 0509850 27.09.05 FR

Filing date 25 September 2006

Wipo publication date 5 April 2007

Acceptance publication date 18 October 2012

International Classifications

C07D 235/30 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 235/32 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 277/82 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/036630 Priority application(s): WO2007/036630

18 October 2012 Application Accepted

  Published as AU-B-2006296468

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006296491-Method for making a food or biotechnological product using redox potential regulation

2006296464-Polarising ophthalmic lens adapted to a wearer's eye/head behaviour